353 related articles for article (PubMed ID: 18217151)
1. Impact of cytochrome P450 3A4-metabolized statins on the antiplatelet effect of a 600-mg loading dose clopidogrel and on clinical outcome in patients undergoing elective coronary stent placement.
Trenk D; Hochholzer W; Frundi D; Stratz C; Valina CM; Bestehorn HP; Büttner HJ; Neumann FJ
Thromb Haemost; 2008 Jan; 99(1):174-81. PubMed ID: 18217151
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes.
Mitsios JV; Papathanasiou AI; Rodis FI; Elisaf M; Goudevenos JA; Tselepis AD
Circulation; 2004 Mar; 109(11):1335-8. PubMed ID: 15023882
[TBL] [Abstract][Full Text] [Related]
3. The inhibitory potency of clopidogrel on ADP-induced platelet activation is not attenuated when it is co-administered with atorvastatin (20 mg/day) for 5 weeks in patients with acute coronary syndromes.
Mitsios JV; Papathanasiou AI; Elisaf M; Goudevenos JA; Tselepis AD
Platelets; 2005 Aug; 16(5):287-92. PubMed ID: 16011979
[TBL] [Abstract][Full Text] [Related]
4. Lipophilic statins interfere with the inhibitory effects of clopidogrel on platelet function--a flow cytometry study.
Neubauer H; Günesdogan B; Hanefeld C; Spiecker M; Mügge A
Eur Heart J; 2003 Oct; 24(19):1744-9. PubMed ID: 14522569
[TBL] [Abstract][Full Text] [Related]
5. Multiple antiplatelet effects of clopidogrel are not modulated by statin type in patients undergoing percutaneous coronary intervention.
Smith SM; Judge HM; Peters G; Storey RF
Platelets; 2004 Dec; 15(8):465-74. PubMed ID: 15763887
[TBL] [Abstract][Full Text] [Related]
6. A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.
Wenaweser P; Eshtehardi P; Abrecht L; Zwahlen M; Schmidlin K; Windecker S; Meier B; Haeberli A; Hess OM
Thromb Haemost; 2010 Sep; 104(3):554-62. PubMed ID: 20664903
[TBL] [Abstract][Full Text] [Related]
7. High-dose atorvastatin on the pharmacodynamic effects of double-dose clopidogrel in patients undergoing percutaneous coronary interventions: The ACHIDO (Atorvastatin and Clopidogrel HIgh DOse in stable patients with residual high platelet activity) study.
Leoncini M; Toso A; Maioli M; Angiolillo DJ; Giusti B; Marcucci R; Abbate R; Bellandi F
JACC Cardiovasc Interv; 2013 Feb; 6(2):169-79. PubMed ID: 23428009
[TBL] [Abstract][Full Text] [Related]
8. The antiplatelet effect of clopidogrel is not attenuated by statin treatment in stable patients with ischemic heart disease.
Vinholt P; Poulsen TS; Korsholm L; Kristensen SR; Hallas J; Damkier P; Mickley H
Thromb Haemost; 2005 Aug; 94(2):438-43. PubMed ID: 16113837
[TBL] [Abstract][Full Text] [Related]
9. Antiplatelet effects of a 600 mg loading dose of clopidogrel are not attenuated in patients receiving atorvastatin or simvastatin for at least 4 weeks prior to coronary artery stenting.
Gorchakova O; von Beckerath N; Gawaz M; Mocz A; Joost A; Schömig A; Kastrati A
Eur Heart J; 2004 Nov; 25(21):1898-902. PubMed ID: 15522468
[TBL] [Abstract][Full Text] [Related]
10. Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial.
Saw J; Steinhubl SR; Berger PB; Kereiakes DJ; Serebruany VL; Brennan D; Topol EJ;
Circulation; 2003 Aug; 108(8):921-4. PubMed ID: 12925453
[TBL] [Abstract][Full Text] [Related]
11. Myonecrosis after elective percutaneous coronary intervention: effect of clopidogrel-statin interaction.
Gulec S; Ozdol C; Rahimov U; Atmaca Y; Kumbasar D; Erol C
J Invasive Cardiol; 2005 Nov; 17(11):589-93. PubMed ID: 16264203
[TBL] [Abstract][Full Text] [Related]
12. Effect of atorvastatin and pravastatin on platelet inhibition by aspirin and clopidogrel treatment in patients with coronary stent thrombosis.
Wenaweser P; Windecker S; Billinger M; Cook S; Togni M; Meier B; Haeberli A; Hess OM
Am J Cardiol; 2007 Feb; 99(3):353-6. PubMed ID: 17261397
[TBL] [Abstract][Full Text] [Related]
13. Statins do not adversely affect post-interventional residual platelet aggregation and outcomes in patients undergoing coronary stenting treated by dual antiplatelet therapy.
Geisler T; Zürn C; Paterok M; Göhring-Frischholz K; Bigalke B; Stellos K; Seizer P; Kraemer BF; Dippon J; May AE; Herdeg C; Gawaz M
Eur Heart J; 2008 Jul; 29(13):1635-43. PubMed ID: 18503057
[TBL] [Abstract][Full Text] [Related]
14. Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial.
Saw J; Brennan DM; Steinhubl SR; Bhatt DL; Mak KH; Fox K; Topol EJ;
J Am Coll Cardiol; 2007 Jul; 50(4):291-5. PubMed ID: 17659194
[TBL] [Abstract][Full Text] [Related]
15. Accelerated platelet inhibition by switching from atorvastatin to a non-CYP3A4-metabolized statin in patients with high platelet reactivity (ACCEL-STATIN) study.
Park Y; Jeong YH; Tantry US; Ahn JH; Kwon TJ; Park JR; Hwang SJ; Gho EH; Bliden KP; Kwak CH; Hwang JY; Kim S; Gurbel PA
Eur Heart J; 2012 Sep; 33(17):2151-62. PubMed ID: 22507978
[TBL] [Abstract][Full Text] [Related]
16. Lack of clopidogrel-statin interaction in patients undergoing coronary stent implantation.
Serrano Júnior CV; Soeiro Ade M; Araújo LF; Jabot B; Rached F; Orii NM; Nicolau JC; Duarte AJ; Ramires JA
Arq Bras Cardiol; 2010 Sep; 95(3):321-7. PubMed ID: 20721515
[TBL] [Abstract][Full Text] [Related]
17. Influence of statin treatment on platelet inhibition by clopidogrel - a randomized comparison of rosuvastatin, atorvastatin and simvastatin co-treatment.
Malmström RE; Ostergren J; Jørgensen L; Hjemdahl P;
J Intern Med; 2009 Nov; 266(5):457-66. PubMed ID: 19549094
[TBL] [Abstract][Full Text] [Related]
18. Platelet reactivity and clinical outcomes in patients using CYP3A4-metabolized statins with clopidogrel in percutaneous coronary intervention.
Park JS; Cha KS; Lee HW; Oh JH; Choi JH; Lee HC; Hong TJ; Kim HS;
Heart Vessels; 2017 Jun; 32(6):690-699. PubMed ID: 27904973
[TBL] [Abstract][Full Text] [Related]
19. Absence of interaction between atorvastatin or other statins and clopidogrel: results from the interaction study.
Serebruany VL; Midei MG; Malinin AI; Oshrine BR; Lowry DR; Sane DC; Tanguay JF; Steinhubl SR; Berger PB; O'Connor CM; Hennekens CH
Arch Intern Med; 2004 Oct; 164(18):2051-7. PubMed ID: 15477442
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents.
Trenk D; Hochholzer W; Fromm MF; Chialda LE; Pahl A; Valina CM; Stratz C; Schmiebusch P; Bestehorn HP; Büttner HJ; Neumann FJ
J Am Coll Cardiol; 2008 May; 51(20):1925-34. PubMed ID: 18482659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
